2.3. Analysis of PARP1 and APE1 mRNA Expression in MDS/CMML and AML Cells in Correlation to Cytotoxic Efficacy of Talazoparib and APE1 Inhibitor III. This evidence concerns the gene PARP1 and acute myeloid leukemia.